Fosamax MDL Transfer Delayed
U.S. District Judge John Keenan, who is presiding over the Fosamax MDL over jaw injuries allegedly caused by the bone drug, has delayed the transfer of hundreds of lawsuits back to their original districts. The decision was made to give plaintiffs and defendant, Merck & Co. Inc., additional time to reach a potential settlement.
The transfer, effectively disbanding the MDL, was originally slated to begin starting November 1, but will now begin on December 2.
About Fosamax lawsuits
Fosamax is part of the bisphosphonates group of medicines. It works to modify the cycle of bone formation and breakdown in the body. Alendronate sodium in the drug slows bone loss, while increasing bone mass, which may prevent bone fractures. Fosamax is used to treat or prevent osteoporosis caused by menopause in woman. Men with osteoporosis often take the drug to increase bone mass. It’s also used to treat Paget’s disease in both men and women.
Plaintiffs in the MDL claim they have suffered osteonecrosis of the jaw, generally following invasive dental procedures, such as tooth extraction or dental implants and/or delayed healing, in association with the use of Fosamax.
An order filed August 29, 2013 by Judge Keenan states, “The Court has tried five cases as bellwethers and general expert discovery has taken place. In this Court’s view, all that is left for each of the cases in this MDL is case specific discovery and trial. To that end, the district courts to which these cases will be remanded will have the benefit of this Court’s omnibus Daubert ruling as well as numerous other opinions issued throughout this litigation…”
Benefits of Fosamax jaw injury lawsuit loans
Beginning December 2, Judge Keenan has ordered that 200 cases per month will be returned to their home districts, starting with the oldest cases. As of the summer 2013, more than 1,000 cases were part of the MDL, meaning the transfer process will take six months to complete. Even after the case is returned to its home district, it could take months or even years to reach a ruling.
Many plaintiffs have used up all of their personal income and simply don’t have any more money left to spare, even if the ruling is likely to be in their favor. Fosamax jaw injury lawsuit loans can help plaintiffs to make ends meet until they receive money from a settlement.
LawStreet Capital specializes in providing pre-settlement loans for plaintiffs awaiting compensation from products liability cases and those involving dangerous drugs. Fosamax lawsuit funding can help patients to avoid settling for less than they deserve, working to bridge the gap between filing a complaint and receiving a payout. This process can take years and many plaintiffs literally can’t afford to wait that long.
Need cash now? Apply for lawsuit funding today!
LawStreet Capital assumes all risk, so the cash advance is only repaid if you win or settle your claim. There’s no risk involved and our interest rates are among the most competitive around. Our legal experts are well-versed in the ongoing Fosamax litigation against Merck, so we understand the financial and subsequent psychological burden this can place on you and your family, while awaiting justice for your injury.
Once approved, a cash advance can be placed in your bank account fast — often within 24 hours. To find out more about Fosamax lawsuit funding, contact LawStreet Capital toll-free at 1.866.FUND.662.
